Literature DB >> 27656849

Disease-free survival in patients with non-metastatic breast cancer.

Roberta Wolp Diniz1, Maximiliano Ribeiro Guerra2, Jane Rocha Duarte Cintra3, Vívian Assis Fayer4, Maria Teresa Bustamante Teixeira5.   

Abstract

INTRODUCTION: Breast cancer is the second most common malignancy in the world and the one with highest incidence in the female population; it is also a major cause of death from cancer among women.
OBJECTIVE: To analyze the disease-free survival (DFS) at 5 years and prognostic factors in women with non-metastatic invasive breast cancer treated at a referral center for cancer care located in a medium-sized city in the Southeast of Brazil.
METHOD: Patients diagnosed with the disease between 2003 and 2005 and identified through the institution's cancer hospital records were analyzed. The follow-up of cases was carried out through hospital records, and complemented by search in the database of the Mortality Information System (SIM) as well as telephone contact. The variables analyzed were distributed in the following blocks: socio-demographic data, tumor-related characteristics, and treatment-related characteristics. Survival functions were calculated using the Kaplan-Meier method and the prognostic factors were analyzed based on Cox proportional hazard model.
RESULTS: The study showed a DFS at 5 years of 72% (95CI 67.6-75.9). The main variables independently associated with DFS were lymph node involvement, use of hormone therapy, and education level.
CONCLUSION: This study reinforces the importance of early diagnosis for DFS, pointing to the role of social aspects in this regard. The relevance of this research in the country is also highlighted, given the scarcity of studies on DFS in the Brazilian population.

Entities:  

Mesh:

Year:  2016        PMID: 27656849     DOI: 10.1590/1806-9282.62.05.407

Source DB:  PubMed          Journal:  Rev Assoc Med Bras (1992)        ISSN: 0104-4230            Impact factor:   1.209


  7 in total

1.  Evolutionary aspects of non-metastatic breast cancer after primary treatment in a sub-Saharan African setting: a 16-year retrospective review at the Douala general hospital, Cameroon.

Authors:  Bibiana Ateh Nzeangung; Martin Essomba Biwole; Benjamin Momo Kadia; Ndemazie Nkafu Bechem; Christian Akem Dimala; Albert Mouelle Sone
Journal:  BMC Cancer       Date:  2018-01-05       Impact factor: 4.430

2.  Landmark Prediction of Survival for Breast Cancer Patients: A Case Study in Tehran, Iran.

Authors:  Behnaz Alafchi; Leili Tapak; Omid Hamidi; Jalal Poorolajal; Hossein Mahjub
Journal:  Iran J Public Health       Date:  2019-12       Impact factor: 1.429

3.  Pattern of survival of breast cancer patients in a tertiary hospital in South West Nigeria.

Authors:  Musa Ali-Gombe; Muhammad Inuwa Mustapha; Ayorinde Folasire; Atara Ntekim; Oladapo Babatunde Campbell
Journal:  Ecancermedicalscience       Date:  2021-02-25

4.  Undetected αKlotho in serum is associated with the most aggressive phenotype of breast cancer.

Authors:  Bruna Cristina Borges; Pedro Augusto Do Amaral; Luiz Ricardo Soldi; Victor Luigi Costa Silva; Fernanda Carvalho De Souza; Felipe Andrés Cordeiro Da Luz; Rogério Agenor De Araújo; Marcelo José Barbosa Silva
Journal:  Mol Clin Oncol       Date:  2022-02-25

5.  Determining Prognostic Factors of Disease-Free Survival in Breast Cancer Using Censored Quantile Regression.

Authors:  Akram Yazdani; Shahpar Haghighat
Journal:  Breast Cancer (Auckl)       Date:  2022-06-29

6.  Completeness and Consistency of Epidemiological Variables from Hospital-Based Cancer Registries in a Brazilian State.

Authors:  Luís Carlos Lopes-Júnior; Larissa Soares Dell'Antonio; Raphael Manhaes Pessanha; Cristiano Soares Dell'Antonio; Michelaine Isabel da Silva; Thayna Mamedi de Souza; Jonathan Grassi
Journal:  Int J Environ Res Public Health       Date:  2022-09-22       Impact factor: 4.614

Review 7.  Relationship of Socio Economic Status, Income, and Education with the Survival Rate of Breast Cancer: A Meta-Analysis.

Authors:  Majid Taheri; Mohammad Tavakol; Mohammad Esmaeil Akbari; Amir Almasi-Hashiani; Mahmoud Abbasi
Journal:  Iran J Public Health       Date:  2019-08       Impact factor: 1.429

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.